Factrel Articles
Zoladex licensed for new indication in UK
31 August 2001
Euro Epidemiology TrendsTo Year 2010; Cancer
17 October 1994
ARES-SERONO PIPELINE OVERVIEW
31 May 1993
Showing 1-4 of 4 articles
- 1
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
